
DRUG vs NGEN
$DRUG vs $NGEN head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DRUG vs NGEN: trend, levels and the market
One year to 2026-11-18, against the S&P 500 (+5.9%). Split-adjusted daily closes.
- ·DRUG is the weaker of the two on trend, below both its 50- and 200-day averages, while NGEN has held above one of them.
- ·Neither kept up with the market over the past year: DRUG -76.9% and NGEN -68.2%, against the S&P 500 at +5.9%.
- ·NGEN has support 11.9% below at $1.68; DRUG has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
DRUG vs NGEN: the quick read
- ·NGEN is the larger company by market cap ($211M vs $202M).
- ·NGEN has been more active on our scanner (112 vs 98 alerts in 30 days).
- ·DRUG has the smaller float (8.5M vs 107.5M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: NGEN is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·Both stay busy on our scanner, 112 and 98 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 4% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·NGEN is the one in play today, trading about 3.0x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Watching DRUG or NGEN? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DRUG and NGEN on TheDesperateTrader.
- Is DRUG or NGEN the better stock?
- "Better" depends on your goal, and these two are not alike. NGEN is the larger company by market cap ($211M vs $202M). NGEN has been more active on our scanner (112 vs 98 alerts in 30 days). DRUG has the smaller float (8.5M vs 107.5M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DRUG and NGEN?
- The differences that matter: they are similar in size ($202M vs $211M); they trade at very different share prices ($20.76 vs $1.91); DRUG sits at 3% of its 52-week range against 13% for NGEN; our scanner flagged DRUG 98 times in the last 30 days against 112 for NGEN. Everything above is measured from the latest completed session and SEC filings.
- Which of DRUG and NGEN is more active right now?
- Right now DRUG is at about 0.7x its normal volume and NGEN is at about 3.0x, so NGEN is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is DRUG or NGEN in the stronger trend?
- DRUG is below its 50-day average of $46.25 and below its 200-day average of $69.26; NGEN is above its 50-day average of $1.72 and below its 200-day average of $2.63. NGEN leads 5 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DRUG or NGEN? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.